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This report describes induction of HIV-1 resistance and synthesis of resistance factors in immortal CD4-positive T
lymphocytes. SupT1 cells were infected by NL4-3 attenuated by a defect in the vif gene through coculture with infected
primary lymphocytes. Cell lines from this infection, termed R1, expressed CD4 and CXCR4, carried low levels of HIV-1 DNA,
but expressed no other detectable viral products and were resistant to infection by wild-type HIV-1. Investigation of challenge
infection in resistant R1 lines demonstrated entry, reverse transcription, and integration by incoming HIV-1 but no synthesis
of viral RNA. By assay of marker gene expression, we found that Tat was unable to activate LTR-driven transcription in R1
lines. HIV-1-resistant R1 lines secreted soluble factors that inhibited productive infection of primary lymphocytes by several
strains of HIV-1 and blocked viral RNA synthesis in newly infected cells. Resistance factors also blocked the induction
of HIV-1 transcription in ACH-2 cells as assayed by viral antigen expression and Northern blot of viral RNA. SolubleINTRODUCTION
Human beings possess multiple strategies to control
viral replication and pathogenesis. During the natural
history of many viral infections, some infected individuals
demonstrate protective immunity, in which exposure to
virus elicits viral antigen-specific immune responses that
control later infections (Hillemann, 1989). It is generally
accepted that if this condition obtains, antiviral vaccines
can be developed that also induce protective immunity
(Hillemann, 1989). Considering human immunodefi-
ciency virus type 1 (HIV-1) infection in humans, there is
evidence for generation of protective cytotoxic and non-
cytotoxic T cell responses among some multiply ex-
posed, uninfected persons (Rowland-Jones et al., 1995;
Stranford et al., 1999) and research is ongoing to repro-
duce these responses by immunization (Berzofsky, 1991;
Levy, 1993). However, much of the previous research
effort has been directed toward induction of neutralizing
antibodies against HIV-1, but there is little evidence that
such antibodies are protective during natural infection
(Berzofsky, 1991; Levy, 1993). Several factors undoubtedly
1 To whom correspondence and reprint requests should be ad-
dressed at the Molecular Virology Division, St. Luke’s–Roosevelt
Hospital Center, 432 West 58th Street, Antenucci Research Building,contribute to the difficulty, with the most prominent likely
to be the conformation of the target antigen often em-
ployed, HIV-1 envelope gp120. X-ray crystallography of a
complex of deglycosylated gp120–CD4-neutralizing anti-
body fragment revealed that neutralizing epitopes are
inaccessible to antibody in the native state and may be
only transiently available upon receptor ligation (Kwong
et al., 1998). Together these studies indicate that further
research is required before protective antigen-specific
responses to HIV-1 can be elicited at will.
In alternative protective pathways, human cells can
synthesize biologically active proteins that interfere with
viral replication, but are not viral antigen specific. One
goal for antiviral therapy is to devise means to induce
effective concentrations of endogenous viral inhibitors to
provide an internal defense against viral infection. HIV-1
replication is sensitive to several viral inhibitors of cel-
lular origin. The interferons and interferon-regulated pro-
teins are exemplars of this class (Korth et al., 1998;
Samuel, 1991). In certain experimental models interferon
I is active against HIV-1, but there is no consensus on the
mechanism of action operative (Korth et al., 1998).  and
 chemokines have been shown to block replication of
HIV-1 strains, which must interact with the cognate che-
mokine receptors for efficient viral–cell fusion (Cocchi et
al., 1995; Oberlin et al., 1996). CD8-bearing T lympho-
cytes secrete inhibitory chemokines and they also se-factors produced by HIV-1-resistant, immortal R1 cells m
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remain unidentified (Blackbourn et al., 1996; Mackewicz
et al., 1995; Scala et al., 1997). The latter two mecha-
nisms have each been implicated in the control of dis-
ease progression in certain HIV-1-exposed or -infected
persons (Blackbourn et al., 1996; Rowland-Jones et al.,
1995; Scala et al., 1997; Stranford et al., 1999), raising the
possibility that human cells can be triggered by HIV-1 to
elaborate protective antiviral responses, distinct from
classical cellular or humoral immunity.
We have established conditions for the maintenance
of Vif-negative HIV-1 in peripheral blood lymphocytes
(PBL) to study the requirement for the viral protein Vif for
HIV-1 replication and to investigate cellular responses to
long-term infection (Simm et al., 2000). Consistent with
previous studies (Akari et al., 1992; Fisher et al., 1987;
Gabuzda et al., 1994; Simm et al., 1995; von Schwedler et
al., 1993) Vif-negative infection of PBL was poorly pro-
ductive and noncytolytic. Unexpectedly, PBL cultures car-
rying Vif-negative HIV-1 were found to resist infection by
wild-type HIV-1, and resistant CD4-positive cells from
these cultures were found to secrete soluble factors that
conferred resistance upon uninfected PBL across a po-
rous membrane (Simm et al., 2000). We found that resis-
tant CD4-bearing cells permitted entry and reverse tran-
scription of incoming HIV-1 but failed to synthesize de-
tectable viral RNA. In the present work we report
establishment of this resistance to HIV-1 in SupT1 cells,
determine the mechanism by which cells resist produc-
tive infection, and demonstrate the breadth and site of
activity of HIV-1 resistance factors produced by resistant
SupT1 (R1) cell lines.
RESULTS
Establishment and characteristics of transformed
T cell lines resistant to HIV-1 infection
We recently reported that resistance to HIV-1 can be
induced by long-term infection of PBL by HIV-1 rendered
Vif-negative through a 35-bp deletion in the vif gene
(Simm et al., 2000). To facilitate studies of the mechanism
of this resistance, we attempted to generate HIV-1-resis-
tant immortal cells. To this end we performed cell–cell
transmission of Vif-negative HIV-1 by cocultivation of
infected resistant PBL with SupT1, a T leukemia cell line
that is permissive to Vif-negative HIV-1 infection (Simm et
al., 1995; Smith et al., 1984; von Schwedler et al., 1993).
Exposed SupT1 failed to produce HIV-1 p24 and did not
suffer HIV-1 cytopathic effects (not shown). The SupT1
cells resulting from the 4-week cocultivation period were
termed R1. The absence of p24 production by R1 con-
trasts with infection of SupT1 by cell-free Vif-negative
virus produced by PBL (Simm et al., 1995) and was
consistent with the transfer of resistance during coculti-
vation. We therefore tested R1 cells and parental SupT1
cells for susceptibility to wild-type HIV-1 replication.
Cells were exposed to HIV NL4-3 at a multiplicity of
infection of 0.1 and infection was monitored by measur-
ing extracellular p24 (Fig. 1A). SupT1 cells expressed
high levels of p24, but R1 was resistant to productive
infection by NL4-3. Thus cocultivation with HIV-1-resis-
tant PBL carrying Vif-negative HIV-1 conferred the HIV-1
resistance phenotype upon SupT1 cells generating the
HIV-1-resistant R1 cell line. This entire procedure for
generation of HIV-1-resistant SupT1 cells by attenuated
HIV-1 infection was repeated twice with similar results
(not shown).
We subcultured R1 cells by limiting dilution to isolate
HIV-1-resistant lines for further analysis. Cell line R1c2
was tested for susceptibility to wild-type NL4-3 infection
by measurement of extracellular p24 (Fig. 1B) or bulk
HIV-1 antigens detected by immunofluorescent staining
using AIDS serum (Fig. 1C). SupT1 was highly suscepti-
ble to infection, but R1c2 was resistant. Similarly, all 10
lines of R1 tested for susceptibility to HIV were found to
be resistant (not shown). The degree of resistance
ranged from 88 to 99.9%. Because of the extent of their
resistance, R1c2 and R1c3 or their derivatives were used
for the remainder of the studies in this paper.
To determine whether their resistance was linked to
the presence of Vif-negative HIV-1, R1 lines were sub-
jected to PCR amplification of a region from HIV-1 gag
(Fig. 2A). Like Vif-negative virus-infected PBL (Simm et
al., 2000), R1 lines carried HIV-1 DNA at low copy num-
bers, one copy in 10–1000 cells. We were unable to
isolate lines of R1 that maintained one copy of viral DNA
per cell or that lost all detectable viral DNA. To test the
expression of resident virus, R1c3 and R1c10 were also
tested for the presence of HIV-1 gag RNA by RT-PCR;
acutely infected SupT1 served as a positive control (Fig.
2B). RNA samples were or were not subjected to reverse
transcription prior to amplification to distinguish poten-
tial carryover DNA from RNA. Viral RNA was not detected
in cells or in sedimentable extracellular particles in R1c3
or R1c10. These findings indicate that the Vif-negative
HIV-1 resident in R1 lines is not efficiently expressed in
RNA. Taken together, these studies demonstrate estab-
lishment of HIV-1-resistant, immortalized T cells and iso-
lation of multiple HIV-1-resistant T cell lines and provide
a tractable system for analysis of this route of HIV-1
resistance.
In some cell lines, resistance to HIV-1 can be acquired
by reduction of the display of viral receptors (Asjo et al.,
1987). Therefore, R1c2 cells were tested by flow cytom-
etry for their expression of CD4 and CXCR4, the receptor
and coreceptor, respectively, for NL4-3 (Feng et al., 1996).
SupT1 cells were stained in parallel as a positive control
(Fig. 3). Both cell types carried high levels of CD4 and
CXCR4, although SupT1 showed a slightly higher density
of CD4 than R1c2 and R1c2 showed a slightly higher
density of CXCR4 than parental SupT1. Similar results
were obtained using R1c3 and R1c10 (not shown). R1c2
and SupT1 were also tested for the presence of intracel-
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lular interferon- by flow cytometry and both showed no
staining above background (not shown). We conclude
that neither down-modulation of viral receptors nor ex-
pression of interferon- can account for the resistance of
R1 lines to HIV-1.
The basis of HIV-1 resistance in R1 cells: R1c2 cells
are susceptible to HIV-1 entry, reverse transcription,
and DNA integration but arrest infection at the level
of transcription
To determine the basis of their resistance, R1 cells
were infected by NL4-3, and specific steps in viral rep-
lication were monitored. To investigate the early phases
of HIV-1 replication, we evaluated viral DNA synthesis
and nuclear entry following exposure of R1c2 to NL4-3.
R1 lines carry low levels of unexpressed Vif-negative
viral DNA that could obscure detection of newly synthe-
sized DNA (Fig. 2A). Therefore we reduced the number of
cycles of amplification so that resident viral DNA was not
detected (see 0° lane in Fig. 4A). We amplified strong-
stop DNA, full-length DNA, and two-LTR circular DNA to
monitor partial and complete reverse transcripts and
nuclear translocation of viral DNA, respectively (Figs. 4A
and 4B). DNA content in cell lysates was standardized by
amplification of -globin DNA. HIV-1 infections of R1c2
and SupT1 were comparable at the level of viral DNA
synthesis; reverse transcription was completed in both
cell types, and viral DNA entered nuclei, the latter as
indicated by the presence of two-LTR circular DNA (Figs.
4A and 4B). To investigate whether viral DNA was effi-
ciently integrated in resistant cells we performed nested
Alu-PCR based on a recently described strategy (Butler
et al., 2001; Wu and Marsh, 2001) using a primer from
human repetitive DNA and a primer from the region in
the HIV-1 genome absent from resident Vif-negative
HIV-1 and a second round of PCR using two Vif primers:
one within and one outside the deletion. These condi-
tions should amplify incoming intact HIV-1 DNA only
when integrated and in cis to an Alu sequence in cellular
DNA (Fig. 4C). When amplification was conducted with-
FIG. 1. Vif-negative HIV-1-infected R1 cells and cell lines are resistant to HIV-1 infection. (A) R1 cells or parental SupT1 cells were infected by NL4-3.
(B) Cell line R1c2 or parental SupT1 cells were infected by NL4-3. HIV-1 expression was measured by assay of extracellular p24. (C) HIV-1 expression
was demonstrated by indirect immunofluorescent staining using AIDS serum; left, R1c2; right, SupT1.
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out the Alu primer in the first round, the efficiency of
detection of integrated DNA in ACH-2 cells was much
lower. Unintegrated, intact viral DNA can also be de-
tected by this limited amplification. Adding the Alu primer
permitted amplification of integrated DNA present in
ACH-2 and in acutely infected cells, 72 h after infection.
It is clear that integration of viral DNA occurred in resis-
tant R1c2 as well as susceptible SupT1 clone S-3, ap-
parently with greater efficiency although nested PCR is
not strictly quantitative. These findings indicate that the
early phases of NL4-3 infection, viral binding and fusion,
uncoating, reverse transcription, nuclear localization,
and integration of viral DNA, are efficient in HIV-1-sus-
ceptible SupT1 and -resistant R1c2 cells and point to
later stages of viral replication for the imposition of re-
sistance observed in R1c2.
Multiple viral and cellular factors regulate the synthe-
sis of viral RNA (Levy, 1993), making it an attractive
candidate for the control of HIV-1 in resistant R1c2. To
determine if the block to HIV-1 replication in R1c2 cells is
imposed after nuclear entry of viral DNA but before
transcription, we isolated RNA from cells 5 days after
NL4-3 infection and subjected samples to RT-PCR, am-
plifying a region from tat present in spliced RNA and a
region from gag present in unspliced RNA (Figs. 5A and
5B). NL4-3-infected SupT1 served as a positive control.
RNA content in samples was standardized by the levels
FIG. 2. R2 cells carry, but do not express, HIV-1 DNA. (A) R1 cell lines
were subjected to PCR amplification of HIV-1 gag DNA. Lysates of
150,000 cells were used for amplification except for R1c2, for which
30,000 cells were used, and R1c4, for which 75,000 cells were used.
Lysates from the indicated number of 8E5 cells were amplified in
parallel to serve as a standard. (B) R1 cell lines were subjected to
RT-PCR amplification of gag RNA. RNA was isolated from equal num-
bers of cells or from their supernatants subjected to high-speed cen-
trifugation to isolate particulate matter. RNA was or was not subjected
to reverse transcription, as indicated, and then subjected to PCR
amplification of HIV-1 gag. Samples from acutely infected SupT1
served as positive controls.
FIG. 3. R1c2 carries surface membrane CD4 and CXCR4. R1c2 and SupT1 cells were labeled with monoclonal anti-CD4, anti-CXCR4, or
isotype-matched control mouse Ig and were subjected to flow cytometry. Fluorescence intensity is shown on the x axis and cell number is shown
on the y axis.
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FIG. 4. R1c2 permits HIV-1 entry and reverse transcription but restricts HIV-1 transcription. R1c2, SupT1, and its clone, S-3, were infected with NL4-3.
(A) At the times indicated after infection cell lysates were prepared and subjected to PCR amplification of strong-stop and full-length viral DNA. The
indicated numbers of plasmid copies were amplified in parallel to serve as a standard. (B) Infected cell lysates were subjected to PCR amplification
of two-LTR circular viral DNA. (C) DNA from cells collected at 0 or 72 h after infection was subjected to nested PCR amplification using primers for
cellular Alu repetitive sequences and for Vif as described under Materials and Methods. DNA from the indicated number of ACH-2 cells was amplified
in parallel for comparison.
FIG. 5. R1c2 arrests HIV-1 replication at transcription. (A and B) RNA was isolated from cells 5 days after infection and RNA from the indicated
number of cells was subjected to RT-PCR amplification of viral tat or gag RNA as indicated. The lanes labeled 0° indicate cells which were infected
for 1 h on ice prior to harvest.
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of -actin RNA. No products were detected when reverse
transcription of RNA was omitted, indicating that no viral
DNA was present in the reaction (not shown). Similarly
no viral RNA was detected in R1c2 cells mock infected at
0°C, indicating that the resident Vif-negative HIV-1 is not
efficiently transcribed (see also Fig. 2B). Doubly spliced
RNA encoding tat was detected in 340 SupT1 cells but
was not clearly detected in 10-fold more R1c2 cells (Fig.
5A). Using RNA from a larger number of cells, unspliced
viral RNA was detectable in NL4-3-infected R1c2 cells
but was approximately 600-fold less abundant than in
NL4-3-infected SupT1 (Fig. 5B). These findings suggest
that HIV-1 replication arrested at transcription in R1c2
cells.
To determine the efficiency of HIV-1 transcription R1c2
cells, we measured the expression of a marker protein,
chloramphenicol acetyl transferase (CAT), under tran-
scriptional control of the HIV-1 LTR (Golub et al., 1990).
Transfection of the CAT-encoding plasmid, in the pres-
ence and absence of a plasmid encoding HIV-1 Tat,
permits analysis of basal transcription and Tat-mediated
transactivation (Golub et al., 1990). R1c2 cells and paren-
tal SupT1 cells were transfected and after 3 days CAT
activity in cell lysates was measured by two methods:
scintillation counting and thin-layer chromatography of
labeled reaction products. Jurkat cells constitutively ex-
pressing Tat served as a positive control for CAT trans-
fection and activity (Caputo et al., 1990). The data re-
ported are the averages of two measurements (Figs. 6A
and 6B). CAT was equally well expressed in the absence
of Tat in SupT1 and R1c2, indicating no major differences
between the two cell types in basal LTR-driven transcrip-
tional activity. In contrast, Tat activated LTR-driven CAT
expression 58-fold in SupT1 but increased transcription
from the HIV-1 LTR less than 2-fold in R1c2. Similar
results were obtained in three independent experiments.
Thus Tat-mediated transactivation of HIV-1 LTR-driven
transcription was inefficient in R1c2 cells, confirming that
the overall process of HIV-1 transcription is the site of
HIV-1 arrest in R1c2 and suggesting that the complex of
host factors needed for HIV-1 transcription is altered in
R1c2 versus SupT1.
R1 cells secrete factors that confer
strain-independent resistance to
HIV-1 upon primary T lymphocytes
The R1 lines described here consist of a minority of
Vif-negative HIV-1-infected cells and a majority of unin-
fected cells, which as a group resist wild-type HIV-1
(Figs. 1 and 2). This observation suggested that within R1
cell populations, infected cells secrete factors that con-
fer resistance upon uninfected cells, directly or indirectly.
To test this proposition, we cultured uninfected primary
lymphocytes adjacent to R1c3 in a vessel consisting of
two chambers separated by a porous membrane. We
then infected the lymphocytes with five different primary
HIV-1 isolates or NL4-3 to test the effects of R1c3 prod-
ucts upon HIV-1 replication (Fig. 7). NL4-3 and each
primary isolate infected the lymphocytes, with the pro-
ductivity of infection ranging from 3500 to 310,000 pg p24
per milliliter of culture supernatant. However, when ex-
posed to soluble factors produced by R1c3, PBL ac-
quired resistance to all six HIV-1. Resistant primary CD4-
positive lymphocytes also were able to transmit or in-
duce resistance in naive cells through soluble factors
(Simm et al., 2000).
HIV-1 cell-derived resistance factors arrest HIV-1
replication after DNA synthesis and prior to RNA
synthesis in newly infected cells
Having determined that resistant R1 cells secrete fac-
tors that inhibit new infection in neighboring cells, we
FIG. 6. R1c2 does not support Tat-mediated transactivation of HIV-1
LTR-driven transcription. R1c2 and SupT1 were transfected with a
plasmid encoding HIV-1 LTR-CAT either alone or in the presence of a
plasmid encoding HIV-1 Tat, and 3 days later CAT expression was
determined. Jurkat-Tat cells, which constitutively express HIV-1 Tat
(Caputo et al., 1990), served as a positive control for Tat activation of
CAT expression. The indicated amounts of purified CAT protein were
run as assay standards. (A) The results of counting [14C]chlorampheni-
col in cell extracts in a scintillation counter and (B) the same reaction
products of CAT separated by thin-layer chromatography.
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investigated the stage of viral replication at which infec-
tion was arrested. We subcultured R1c2, generating 18
resistant cell lines, including R1c2.12, and 2 susceptible
cell lines, including R1c2.9. This closely related pair of
cell lines, both of which carry Vif-negative HIV-1 DNA,
was used for controlled analysis of secreted resistance
factors. The format of these experiments was similar to
that described in the previous section; SupT1 cells were
cultured adjacent to R1c2.12 or R1c2.9 cells prior to
infection by NL4-3. Infected SupT1 cells were then har-
vested at various times after viral exposure and tested
for levels of HIV-1 DNA and RNA by PCR (Fig. 8). As
shown in Fig. 8A, synthesis of incomplete and complete
viral DNA was similar in SupT1 whether exposed to
resistant R1c2.12 or control R1c2.9. Localization of viral
DNA in the nucleus was also comparable in infected
SupT1 regardless of treatment (not shown). However, the
levels of viral RNA differed in the two infected cell pop-
ulations (Fig. 8B). Exposure to soluble factors from resis-
tant R1c2.12 blocked the synthesis of detectable levels of
doubly spliced HIV-1 RNA in infected SupT1. In contrast,
doubly spliced RNA was easily detected in infected
SupT1 cultured adjacent to control R1c2.9 cells. We
conclude that factors from resistant cells arrest the
replication of HIV-1 in adjacent cells after viral DNA
synthesis and entry into the nucleus and prior to viral
RNA synthesis.
Resistance factors inhibit the induction of
transcription of latent HIV-1
Findings in the previous section raise the possibility
that resistance factors inhibit transcription of HIV-1 RNA.
We then investigated a system in which viral RNA syn-
thesis can be induced from latent, integrated provirus in
ACH-2 cells (Clouse et al., 1989). These cells constitu-
tively express low levels of viral RNA and protein, but
virus transcription can be induced to high levels by
exposure to phobol 12-myristate 13-acetate (PMA) (Duh
et al., 1989). Since ACH-2 cells already carry integrated
HIV-1, potential defective interfering particles should
have no effect upon their virus expression. ACH-2 were
induced with PMA in normal medium, in the presence of
20% supernatant of R1c2.12, or in the presence of 20%
supernatant of R1c2.9. The induction of HIV-1 was mea-
sured by counting HIV-1 antigen-positive cells after indi-
rect immunofluorescence staining (Fig. 9). Soluble fac-
tors present in the supernatant of an HIV-1-resistant line
inhibited the induction of HIV-1 in ACH-2; control super-
natant from a susceptible line had no effect. To directly
evaluate RNA expression during induction of cells ex-
posed to resistance factors, we performed Northern blot
analysis of viral RNA from ACH-2 cells. We used the
coculture format; ACH-2 was cultured adjacent to resis-
tant R1c2.12 cells prior to 6 h induction with PMA. Unin-
FIG. 7. R1c3 secretes diffusible factors that confer resistance to primary HIV-1 isolates to PBL. HIV-1-negative PBL were cultured alone (triangles)
or adjacent to R1c3 in Transwells (circles). (A–E) PBL were infected with one of five primary isolates of HIV-1. (F) PBL were infected with NL4-3. HIV-1
expression by PBL was measured by assay of extracellular p24.
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duced ACH-2 and induced ACH-2 served as negative
and positive controls, respectively (Fig. 10). It is clear that
PMA induction of ACH-2 increased the level of HIV-1
RNA from undetectable to a level easily detectable by
Northern blot. However, similar to the findings of HIV-1
expression by immunofluorescence (IF) (Fig. 9), expo-
sure of ACH-2 to factors produced by R1c2.12 blocked
ACH-2 induction, which can be ascribed to block of viral
RNA synthesis. As estimated by densitometry after nor-
malization to total RNA levels using Northern blot of
-actin RNA, the reduction in unspliced viral RNA was
50% and the reduction in spliced RNAs was 56%. Taken
together, our data indicate that transformed T cells can
be induced by infection with attenuated virus to enter a
state of resistance to HIV-1 transcription and that resis-
tant cells also secrete factors that confer resistance
upon bystander cells, most likely by inhibition of HIV-1
transcription.
DISCUSSION
Our results introduce a mechanism of transmissible
resistance to HIV-1 infection through soluble factors pro-
duced by CD4-positive T lymphocytes that mediate or
induce inhibition of HIV-1 LTR-driven transcription. Re-
sistance was initiated in T lymphoid R1 cells by exposure
to Vif-negative HIV-1-infected, resistant PBL; thereafter
R1 cells carried unexpressed Vif-negative viral DNA in a
minority of cells; permitted exogenous virus entry, re-
verse transcription, and integration; but arrested HIV-1
replication at transcription. Soluble factors produced by
resistant R1 cells rendered uninfected cells resistant to
FIG. 9. R1c2 supernatant blocks HIV-1 induction in latently infected
cells. ACH-2 cells were cultured in normal medium or in the presence
of 20% supernatant of HIV-1-resistant R1c2.12 or HIV-1-susceptible
R1c2.9 prior to induction with 1 ng/ml PMA. The expression of HIV-1
was monitored by indirect immunofluorescence staining with PMA-
induced cells found to be 9% HIV-1 positive after 16 h treatment. Data
are reported relative to PMA-induced cells.
FIG. 8. R1c2.12 secretes diffusible factors that inhibit HIV-1 RNA synthesis. SupT1 cells cultured adjacent to resistant R1c2.12 and control R1c2.9
were infected with DNase-treated NL4-3 as described under Materials and Methods. (A) At the times indicated after infection cell lysates were
prepared and subjected to PCR amplification of strong-stop and full-length viral DNA. The indicated numbers of plasmid copies were amplified in
parallel to serve as a standard. (B) RNA was isolated form cells 5 days after infection and standardized by amplification of -actin RNA, and RNA was
subjected to RT-PCR amplification of viral tat RNA. The reverse transcription step was omitted from the lanes on the right to confirm that the RNA
preparation contained no viral DNA. The lanes labeled 0°C indicate cells that were infected for 1 h on ice prior to harvest.
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HIV-1 infection most likely through inhibition of viral RNA
transcription. We observed neither viral strain nor host
cell restrictions to this form of resistance to HIV-1.
The arrest of HIV-1 replication in R1 cells was ob-
served first during its establishment by cocultivation with
Vif-negative HIV-1-infected, resistant PBL. In contrast to
our previous observation of infection by cell-free Vif-
negative HIV-1 (Simm et al., 1995) and despite their
general susceptibility to Vif-negative HIV-1 (Simm et al.,
1995; Smith et al., 1984; von Schwedler et al., 1993),
SupT1(R1) cells failed to produce p24 protein or viral
RNA. This observation parallels our recent demonstra-
tion of transmission of an HIV-1-resistance phenotype
from Vif-negative virus-infected PBL (Simm et al., 2000).
We tested R1 resistance by exposure of cells to wild-type
HIV-1 and found that they were not susceptible to HIV-1
replication (Fig. 1). By transfer of the resistance pheno-
type to R1 we established a tractable system for the
analysis of the basis of resistance. Several observations
indicate that resistant R1 cells permit early steps in the
replication of a challenge virus but arrest HIV-1 transcrip-
tion. R1c2 were comparable to parental SupT1 cells in
their levels of the HIV-1 receptors CD4 and CXCR4 (Fig.
3), efficiency of reverse transcription, nuclear localiza-
tion, and integration of viral DNA upon exogenous wild-
type virus infection (Figs. 4A, 4B, and 4C). However, R1c2
cells expressed extremely low levels of viral RNA after
infection (Figs. 5A and 5B) and allowed only minimally
detectable Tat activation of HIV-1 LTR-driven expression
of CAT (Fig. 6). The simplest explanation for these ob-
servations is that the resistance to HIV-1 replication
observed in R1c2 cell populations is imposed during the
process of viral RNA synthesis.
The majority of resistant R1 cells do not carry viral
DNA (Fig. 2), so the presence of Vif-negative HIV-1 DNA
cannot be directly responsible for their resistance. More-
over, cell lines like R1c2.9 can be isolated from resistant
R1c2 cells that regain susceptibility to HIV-1 despite
maintenance of Vif-negative HIV-1 DNA. The most likely
explanation for the resistance phenotype of R1 popula-
tions is the action of soluble resistance factors. Their
activity was directly demonstrated in four ways. First,
turning to the most clinically relevant infection model, we
tested primary HIV-1 infection of PBL for inhibition by
soluble products of R1 cells. A two-chamber culture
apparatus was employed to permit maximal exposure of
the test infection in one chamber to R1 products from
cells cultured in the adjacent chamber. Each of five
primary HIV-1 isolates was inhibited by R1 cell products
(Fig. 7). Second, also using the two-chamber apparatus,
we demonstrated that soluble resistance factors block
viral RNA synthesis in cells newly exposed to HIV-1 (Fig.
8). Third, we found that supernatants of resistant R1c2.12
cells, but not HIV-1-susceptible sister R1c2.9, blocked
short-term induction of HIV-1 in ACH-2 (Fig. 9) (Duh et al.,
1989). Finally, Northern blot analysis of viral RNA in
ACH-2 cells exposed to R1c2.12 confirmed that the block
to proviral induction was mediated at the level of RNA
production (Fig. 10). We conclude that R1 cells secrete
soluble factors that either mediate or induce inhibition of
HIV-1 LTR-driven transcription and inhibit HIV-1 infection.
R1 cells also secrete factors that inhibit induction of
provirus and HIV-1 transcription. Studies are ongoing to
isolate resistance factors and to determine their mech-
anism of action.
Although Vif-negative HIV-1 is not directly responsible
for resistance, it is likely that the imposition of resistance
in R1 is initiated by low-level infection by Vif-negative
virus. It should be noted that in the parallel system of
Vif-negative HIV-1 infection of PBL, we directly demon-
strated that the resident virus maintained the incapaci-
tating deletion in Vif (Simm et al., 2000). R1 cells acquired
resistance after exposure to PBL carrying Vif-negative
virus and the acquisition of resistance coincided with the
acquisition of HIV-1 proviruses in a minority of cells in the
culture (Fig. 2A). HIV-1 DNA was the only viral product
detected in R1 cells, neither viral RNA nor p24 was
detectable (Figs. 1 and 2B). R1 cell lines differed in their
viral DNA copy number but there was no obvious corre-
lation between viral DNA burden and the extent of resis-
tance to HIV-1. Treatment of resistant cells with an inhib-
itor of reverse transcription had varying effects upon the
viral DNA burden but had no effects upon their level of
FIG. 10. R1c2-12 secretes factors that block induction of HIV-1 tran-
scription in latently infected cells. ACH-2 cells were cultured adjacent
to R1c2.12 prior to induction with 5 ng/ml PMA. Cells cultured in normal
medium or after induction with PMA served as controls. Total cellular
RNA isolated from the three cell populations was subjected to Northern
blot analysis (Ausubel et al., 1989).
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resistance. We are investigating other methods to isolate
R1 cells that carry no Vif-negative viral DNA to assess its
linkage with the maintenance of resistance.
In summary, by exposure to Vif-negative HIV-1-infected
PBL, we derived cell lines which resist HIV-1 infection.
R1 cells permit HIV-1 replication through integration of
viral DNA but do not support LTR-driven transcription.
The resistant cells secrete soluble factors that inhibit
transcription and block the replication of HIV-1 in a
strain- and cell type-independent fashion. The ability to
continuously culture R1 cells enables large-scale pro-
duction of resistance factors for isolation and character-
ization.
MATERIALS AND METHODS
Viruses and cells
The HIV-1 clones used in this study were NL4-3 (Ada-
chi et al., 1986) and NL4-3 Vif (Simm et al., 1995). HIV-1
plasmid pNL4-3 (Adachi et al., 1986) was used for prep-
aration of some standard curves in amplification by PCR.
Other standard curves were constructed using 8E5 cells,
carrying a single copy of HIV-1 provirus (Folks et al.,
1986), diluted in uninfected cells. Primary HIV-1 isolates
were obtained by transmission of virus from lymphocytes
from AIDS patients. HIV-1-negative PBL were obtained
from healthy adult donors. All blood donations were
obtained with informed consent. 8E5 (Folks et al., 1986),
ACH-2 (Clouse et al., 1989), and SupT1 (Smith et al., 1984)
were maintained in RPMI, 5% fetal bovine serum, glu-
tamine, and antibiotics. S-3 is a clone of SupT1 that is
highly susceptible to HIV-1.
Establishment of Vif-negative HIV-1-infected SupT1
lines and evaluation of viral resistance
Resistant SupT1 cells were established by cocultiva-
tion with HIV-1-resistant PBL infected by NL4-3 Vif
(Simm et al., 2000) at a 1:1 ratio. The coculture of PBL:
SupT1 was maintained in RPMI without mitogens for 29
days, during which time SupT1 replicated but PBL, lack-
ing mitogens, ceased division and were diluted out.
SupT1, now termed R1, was harvested at the end of
culture. R1 was subcultured by limiting dilution, plating
0.5 cells per well. After 3 weeks of culture, 14 of 160 wells
contained growing cells. R1 cells were evaluated for
susceptibility to productive HIV-1 infection by exposure
to NL4-3 at 0.1 to 1.0 pg p24 per cell and measurement of
extracellular or intracellular p24 core antigen using the
HIV Ag Kit (Coulter, Hialeah, FL). Alternatively an indirect
IF assay for HIV-1 antigens was performed by staining
cells with AIDS serum and fluorescein-conjugated rabbit
anti-human immunoglobulin and examining cells by flu-
orescence microscopy.
Evaluation of soluble resistance factors produced by
R1 cells
Either uninfected PBL or SupT1 or latently infected
ACH-2 cells were cultured in the lower chamber and R1
cells were cultured in the upper chamber of Transwell-
COL plates equipped with a 0.45-m membrane sepa-
rating the two chambers (Corning Costar, Cambridge,
MA). After 4 days, PBL from the lower chamber were
harvested and infected with NL4-3 or mixed with PBL
from one of five AIDS patients, then washed and re-
placed in the lower chamber containing fresh medium.
As controls for PBL infection, cells were infected as
described, but were cultured in flasks. PBL from the
lower chamber or from flasks were tested for HIV-1
expression by measurement of extracellular p24 by
ELISA. Alternatively, SupT1 was used as target, DNase-
treated NL4-3 was used for infection, cells were cultured
adjacent to HIV-1-susceptible R1c2.9 cells as an addi-
tional control, and the progress of infection was moni-
tored by PCR analysis for viral DNA and RNA species. To
test soluble factor activity upon latent/inducible infection,
ACH-2 were cultured in supernatants of resistant or sus-
ceptible cells or were cultured adjacent to R1 cells prior
to and following induction with 1 ng/ml or 5 ng/ml PMA
as described below.
Analysis of HIV-1 DNA and RNA levels by PCR
Cells were prepared and PCR amplification of strong-
stop, full-length, and two-LTR circular HIV-1 DNA was
performed as previously described (Chowdhury et al.,
1996). RNA was isolated using Trizol (Invitrogen Life
Sciences, Gaithersburg, MD) and was converted to
cDNA using Superscript reverse transcriptase (Invitro-
gen) and was subjected to PCR as previously described
(Chowdhury et al., 1996). DNA content was standardized
by amplification of -globin and RNA content was stan-
dardized by amplification of -actin.
Analysis of viral DNA integration by Alu PCR
HIV-1-resistant R1c2 and -susceptible SupT1 S-3 cells
were infected with NL4-3 at an m.o.i. of 0.1 and collected
immediately or after 72 h and DNA was extracted using
DNAzol (GIBCO BRL, Rockville, MD). Using recently pub-
lished methods (Butler et al., 2001; Wu and Marsh, 2001)
we performed nested PCR amplification using primers
from cellular Alu repetitive sequences together with
primers from the region in Vif absent from resident NL4-3
Vif (VIF-DEL-F, 5-GACATCACTATGAAAGCCCTCATCC-
3). The first round of PCR was performed for 40 cycles
using Advantage Genomic Polymerase (Clontech, Palo
Alto, CA) and primers VIF-DEL-F and Alu reverse, SB704,
as described (Butler et al., 2001). The products of this
amplification were then subjected to a second round of
PCR using Taq polymerase (Promega, Madison, WI) and
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Vif primers VIF-DEL-F and VIF 5411 (Sova and Volsky,
1993) for 20 cycles for ACH-2 or 30 cycles for acutely
infected cells. The final 251-bp products were resolved
by electrophoresis and hybridized with a radiolabeled
VIF 5071 probe (Sova and Volsky, 1993).
Flow cytometry
Fluorescence-activated cell sorter analyses were per-
formed on single-cell suspensions using a Coulter Epics
XL-MCL flow cytometer. Cells were stained directly using
enzyme-coupled dye-conjugated anti-CD4 (BD Bio-
sciences, San Diego, CA) or a labeled isotype-matched
control mouse immunoglobulin or in a two-step proce-
dure using mouse monoclonal anti-CXCR4 12G5 (AIDS
Reagent Repository) or control isotype-matched mouse
Ig, followed by phycoerythrin-labeled donkey anti-mouse
IgG (Jackson Immunoresearch Laboratories, West Grove,
PA). To evaluate the intracellular levels of interferon- by
R1c2 cells, permeabilized cells were analyzed by flow
cytometry using the FastImmune Cytokine System (BD
Biosciences) according to the manufacturer’s instruc-
tions. Positive controls were mitogen-activated PBL.
Analysis of chloramphenicol acetyl transferase
expression
Cells were transfected using DEAE-dextran with a
total of 100 ng DNA of pEG602 that encodes bacterial
CAT under the control of the HIV-1 LTR (Golub et al.,
1990) in the presence and absence of pSVTat (obtained
from Dr. C. Rosen). Three days after transfection, cells
were harvested and CAT levels were measured using the
CAT Enzyme Assay System (Promega). Graded amounts
of purified CAT were used as a standard. Extracts of 6 
105 cells were counted in a liquid scintillation counter
and their total counts were reported. Alternatively, reac-
tion products were extracted with ethyl acetate, the ex-
tracts of 3  105 cells were loaded per lane and sepa-
rated by thin-layer chromatography on silica gel plates
using a chloroform:ethanol (97:3) solvent, and the gel
was dried and subjected to autoradiography.
Evaluation of induction of ACH-2 cells
ACH-2 were cultured for 24 h in the presence of 20%
supernatant of an HIV-1-resistant line, R1c2.12; an HIV-1-
susceptible line, R1c2.9; or normal medium. All media
were serum-free. Cells were pelleted and resuspended
in the same medium in the presence or absence of 1
ng/ml PMA for 16 h in serum-free medium. Cells were
then harvested and HIV-1 IF-positive cells were counted.
At least 500 cells from duplicate wells were counted per
system. Alternatively, ACH-2 cells were cultured under
standard conditions or were cultured adjacent to R1c2.12
for 2 days prior to induction with 5 ng/ml PMA. Total RNA
was isolated from each ACH-2 system after 6 h induction
using Trizol (Invitrogen) and was resolved in an agarose/
formaldehyde gel, blotted onto a nylon membrane, and
hybridized with probes for HIV-1 or -actin using the
standard Northern blot procedure (Ausubel et al., 1989).
The HIV-1 probe consisted of two SacI fragments of
pNL4-3, the -actin probe was amplified from cellular
DNA using primers from the RT-PCR Amplifier Set (Clon-
tech), and both probes were labeled with 32P using the
Rad/Prime Kit (Invitrogen).
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